Decreased CFHR4 in HCC might be relevant with resistance of tumor cells against the mechanism of CFHR4-enhanced complement attack as mentioned, leading to the disordered immune regulation and tumor survival from the complement-mediated attack. This evidence concerns the gene CFHR4 and neoplasm.